These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34142957)

  • 1. COVID-19 and Kounis Syndrome: Deciphering Their Relationship.
    Kounis NG; Koniari I; de Gregorio C
    Balkan Med J; 2021 May; 38(3):145-149. PubMed ID: 34142957
    [No Abstract]   [Full Text] [Related]  

  • 2. Kounis Syndrome—not a Single-organ Arterial Disorder but a Multisystem and Multidisciplinary Disease.
    Kounis NG; Koniari I; Velissaris D; Tzanis G; Hahalis G
    Balkan Med J; 2019 Jul; 36(4):212-221. PubMed ID: 31198019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the inflammatory response and megakaryocytes in COVID-19 infection.
    Battina HL; Alentado VJ; Srour EF; Moliterno AR; Kacena MA
    Exp Hematol; 2021 Dec; 104():32-39. PubMed ID: 34563606
    [No Abstract]   [Full Text] [Related]  

  • 4. What triggers severe COVID? Infected immune cells hold clues.
    Mallapaty S
    Nature; 2022 Apr; 604(7905):231. PubMed ID: 35388153
    [No Abstract]   [Full Text] [Related]  

  • 5. Kounis Syndrome Associated With Selective Anaphylaxis to Cefazolin.
    Sequeira T; Gaspar Â; Mota I; Correia M; Chambel M; Morais-Almeida M
    J Investig Allergol Clin Immunol; 2018 Aug; 28(4):257-258. PubMed ID: 30073957
    [No Abstract]   [Full Text] [Related]  

  • 6. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
    Sasidharakurup H; Kumar G; Nair B; Diwakar S
    OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.
    Yang MC; Tsai CC; Su YT; Wu JR
    Kaohsiung J Med Sci; 2021 Mar; 37(3):255-256. PubMed ID: 33400372
    [No Abstract]   [Full Text] [Related]  

  • 8. Rogue antibodies could be driving severe COVID-19.
    Khamsi R
    Nature; 2021 Feb; 590(7844):29-31. PubMed ID: 33469204
    [No Abstract]   [Full Text] [Related]  

  • 9. Kounis Syndrome: a pediatric perspective.
    Giovannini M; Alletto A; Koniari I; Mori F; Favilli S; Sarti L; Barni S; Liccioli G; Lodi L; Indolfi G; Novembre E; Kounis NG
    Minerva Pediatr; 2020 Oct; 72(5):383-392. PubMed ID: 32960008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The neurology of COVID-19].
    Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
    Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary hypersensitivity disorder: the Kounis syndrome.
    Kounis NG
    Clin Ther; 2013 May; 35(5):563-71. PubMed ID: 23490289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A promiscuous interaction of SARS-CoV-2 with bacterial products.
    Carissimo G; Ng LFP
    J Mol Cell Biol; 2020 Nov; 12(12):914-915. PubMed ID: 33326034
    [No Abstract]   [Full Text] [Related]  

  • 14. Kounis syndrome should be excluded when physicians treat patients with anaphylaxis.
    Yanagawa Y; Kondo A; Ishikawa K; Nagasawa H; Takeuchi I; Jitsuiki K; Ohsaka H; Omori K
    Ann Allergy Asthma Immunol; 2017 Oct; 119(4):392. PubMed ID: 28958381
    [No Abstract]   [Full Text] [Related]  

  • 15. C1 Esterase Inhibition: Targeting Multiple Systems in COVID-19.
    Adesanya TMA; Campbell CM; Cheng L; Ogbogu PU; Kahwash R
    J Clin Immunol; 2021 May; 41(4):729-732. PubMed ID: 33474624
    [No Abstract]   [Full Text] [Related]  

  • 16. Mental illnesses among COVID-19 patients: Possible immunological underpinnings.
    Kar SK; Verma P; Verma SK; Saxena SK
    Asian J Psychiatr; 2020 Oct; 53():102376. PubMed ID: 32882669
    [No Abstract]   [Full Text] [Related]  

  • 17. Allergic Acute Coronary Syndrome-Kounis Syndrome.
    Alblaihed L; Huis In 't Veld MA
    Emerg Med Clin North Am; 2022 Feb; 40(1):69-78. PubMed ID: 34782092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and ROS Storm: What is the Forecast for Hypertension.
    de Oliveira AA; Priviero F; Lima VV; Webb RC; Nunes KP
    Am J Hypertens; 2021 Aug; 34(8):779-782. PubMed ID: 34431501
    [No Abstract]   [Full Text] [Related]  

  • 19. Substance P, proinflammatory cytokines, transient receptor potential vanilloid subtype 1 and COVID-19: A working hypothesis.
    Aguirre-Siancas EE; Colona-Vallejos E; Ruiz-Ramirez E; Becerra-Bravo M; Alzamora-Gonzales L
    Neurologia (Engl Ed); 2021 Mar; 36(2):184-185. PubMed ID: 33160723
    [No Abstract]   [Full Text] [Related]  

  • 20. mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
    Rama TA; Moreira A; Castells M
    J Allergy Clin Immunol; 2021 Mar; 147(3):877-878. PubMed ID: 33485650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.